Atlas Trials

PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer

Clinical trial NCT01374789 · TERMINATED

Trial details

NCT number
NCT01374789
Sponsor
WiSP Wissenschaftlicher Service Pharma GmbH
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Urinary Bladder Cancer
Start date
2010-07-01
Primary completion
2012-03-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.